Search results
Results from the WOW.Com Content Network
In 2018, Amneal Pharmaceuticals LLC merged with Impax Laboratories, Inc. to form Amneal Pharmaceuticals, Inc. Shares of newly public AMRX began trading on the NYSE on May 7, 2018. [9] Concurrent with the Impax merger, Amneal acquired Gemini Laboratories for $117 million, including Unithroid, Gemini's lead product for treating hypothyroidism. [10]
Impax Laboratories, Inc. (Impax) is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and ...
Impax Laboratories will release its quarterly report in early November, and investors are bracing themselves for the pharmaceutical company to post a loss, reversing a year-ago profit. But even ...
Impax Laboratories, drug manufacturer; headquarters and a 1.2 billion unit/year production facility [15] [16] [17] Injex Industries (see 2010 top employers) Intarcia Therapeutics; Kobe Steel, Japanese; operates a subsidiary, Kobe Precision [18] Kosan Biosciences, founded in Hayward in 1995 [19] Manheim San Francisco Bay, a division of Manheim ...
Impax Laboratories Enters Into Development, Manufacturing and Commercialization Agreement with Perrigo HAYWARD, Calif.--(BUSINESS WIRE)-- Impax Laboratories, Inc. today announced that it will ...
Impax Environmental Markets, a British company; Impax Laboratories, an American company This page was last edited on 15 ...
What: Shareholders of generic-drug maker Impax. Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're ...
Impax Laboratories Reports First Quarter 2013 Results HAYWARD, Calif.--(BUSINESS WIRE)-- Impax Laboratories, Inc. today reported first quarter 2013 adjusted net income of $25.3 million or $0.37 ...